Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This is a 3-arm, multicenter, double-blind, randomized, placebo-controlled study to evaluate
the efficacy of DR-2001 in endometriosis-related symptoms, primarily nonmenstrual pelvic
pain, over a 12-week treatment period.